Anavex Life Sciences Corp. (AVXL)

5.265 -0.04 (-0.66%) USD  |  NASDAQ  |  Jan 23, 16:00
5.265 0.00 (0.00%) After-Hours: 20:00
More

Anavex Life Sciences CAPEX To Revenue (TTM)

CAPEX To Revenue (TTM) Chart

View CAPEX To Revenue (TTM) for AVXL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View CAPEX To Revenue (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

CAPEX To Revenue (TTM) Range, Past 5 Years

View CAPEX To Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

CAPEX To Revenue (TTM) Benchmarks

View CAPEX To Revenue (TTM) Benchmarks
Start Trial
CorMedix, Inc. Upgrade
Verastem, Inc. Upgrade
Ocugen, Inc. Upgrade
AnaptysBio, Inc. Upgrade
Replimune Group, Inc. --